Logo image of OPXS

OPTEX SYSTEMS HOLDINGS INC (OPXS) Stock Fundamental Analysis

NASDAQ:OPXS - Nasdaq - US68384X2099 - Common Stock - Currency: USD

11.4  -0.67 (-5.55%)

After market: 11.4 0 (0%)

Fundamental Rating

6

Taking everything into account, OPXS scores 6 out of 10 in our fundamental rating. OPXS was compared to 65 industry peers in the Aerospace & Defense industry. Both the health and profitability get an excellent rating, making OPXS a very profitable company, without any liquidiy or solvency issues. OPXS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

OPXS had positive earnings in the past year.
In the past year OPXS had a positive cash flow from operations.
Each year in the past 5 years OPXS has been profitable.
Of the past 5 years OPXS 4 years had a positive operating cash flow.
OPXS Yearly Net Income VS EBIT VS OCF VS FCFOPXS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

The Return On Assets of OPXS (17.78%) is better than 98.46% of its industry peers.
With an excellent Return On Equity value of 22.64%, OPXS belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
OPXS has a Return On Invested Capital of 21.28%. This is amongst the best in the industry. OPXS outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for OPXS is above the industry average of 8.44%.
The last Return On Invested Capital (21.28%) for OPXS is above the 3 year average (13.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.78%
ROE 22.64%
ROIC 21.28%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
OPXS Yearly ROA, ROE, ROICOPXS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 13.05%, OPXS belongs to the top of the industry, outperforming 86.15% of the companies in the same industry.
OPXS's Profit Margin has declined in the last couple of years.
The Operating Margin of OPXS (16.22%) is better than 86.15% of its industry peers.
OPXS's Operating Margin has improved in the last couple of years.
OPXS has a better Gross Margin (28.79%) than 66.15% of its industry peers.
OPXS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.22%
PM (TTM) 13.05%
GM 28.79%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
OPXS Yearly Profit, Operating, Gross MarginsOPXS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so OPXS is creating value.
OPXS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OPXS has been reduced compared to 5 years ago.
OPXS has a better debt/assets ratio than last year.
OPXS Yearly Shares OutstandingOPXS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
OPXS Yearly Total Debt VS Total AssetsOPXS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 10.89 indicates that OPXS is not in any danger for bankruptcy at the moment.
OPXS has a better Altman-Z score (10.89) than 87.69% of its industry peers.
There is no outstanding debt for OPXS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.89
ROIC/WACC2.04
WACC10.43%
OPXS Yearly LT Debt VS Equity VS FCFOPXS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

OPXS has a Current Ratio of 5.06. This indicates that OPXS is financially healthy and has no problem in meeting its short term obligations.
OPXS has a better Current ratio (5.06) than 95.38% of its industry peers.
OPXS has a Quick Ratio of 1.90. This is a normal value and indicates that OPXS is financially healthy and should not expect problems in meeting its short term obligations.
OPXS has a Quick ratio of 1.90. This is in the better half of the industry: OPXS outperforms 66.15% of its industry peers.
Industry RankSector Rank
Current Ratio 5.06
Quick Ratio 1.9
OPXS Yearly Current Assets VS Current LiabilitesOPXS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.64% over the past year.
Measured over the past 5 years, OPXS shows a small growth in Earnings Per Share. The EPS has been growing by 4.27% on average per year.
OPXS shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.77%.
OPXS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.74% yearly.
EPS 1Y (TTM)35.64%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%62.5%
Revenue 1Y (TTM)21.77%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%25.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OPXS Yearly Revenue VS EstimatesOPXS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.06, OPXS is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of OPXS indicates a rather cheap valuation: OPXS is cheaper than 96.92% of the companies listed in the same industry.
OPXS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
Industry RankSector Rank
PE 16.06
Fwd PE N/A
OPXS Price Earnings VS Forward Price EarningsOPXS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OPXS is valued cheaper than 96.92% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OPXS is valued cheaply inside the industry as 96.92% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.77
EV/EBITDA 11.4
OPXS Per share dataOPXS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The excellent profitability rating of OPXS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.76
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OPXS!.
Industry RankSector Rank
Dividend Yield N/A

OPTEX SYSTEMS HOLDINGS INC

NASDAQ:OPXS (7/11/2025, 8:00:02 PM)

After market: 11.4 0 (0%)

11.4

-0.67 (-5.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners34.22%
Inst Owner Change0%
Ins Owners17.87%
Ins Owner Change-6.3%
Market Cap78.77M
AnalystsN/A
Price TargetN/A
Short Float %0.35%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.06
Fwd PE N/A
P/S 2.1
P/FCF 20.77
P/OCF 16.46
P/B 3.65
P/tB 3.81
EV/EBITDA 11.4
EPS(TTM)0.71
EY6.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.55
FCFY4.81%
OCF(TTM)0.69
OCFY6.08%
SpS5.42
BVpS3.12
TBVpS3
PEG (NY)N/A
PEG (5Y)3.76
Profitability
Industry RankSector Rank
ROA 17.78%
ROE 22.64%
ROCE 26.31%
ROIC 21.28%
ROICexc 25.13%
ROICexgc 26.32%
OM 16.22%
PM (TTM) 13.05%
GM 28.79%
FCFM 10.13%
ROA(3y)10.62%
ROA(5y)8.99%
ROE(3y)15.2%
ROE(5y)12.75%
ROIC(3y)13.1%
ROIC(5y)N/A
ROICexc(3y)13.88%
ROICexc(5y)N/A
ROICexgc(3y)14.18%
ROICexgc(5y)N/A
ROCE(3y)16.55%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y0.64%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.31%
OM growth 3YN/A
OM growth 5Y1.7%
PM growth 3Y11.15%
PM growth 5Y-6.48%
GM growth 3Y26.55%
GM growth 5Y1.92%
F-Score7
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 186.84%
Cap/Sales 2.66%
Interest Coverage 123.9
Cash Conversion 72.48%
Profit Quality 77.61%
Current Ratio 5.06
Quick Ratio 1.9
Altman-Z 10.89
F-Score7
WACC10.43%
ROIC/WACC2.04
Cap/Depr(3y)182.71%
Cap/Depr(5y)142.72%
Cap/Sales(3y)2.57%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.64%
EPS 3Y46.13%
EPS 5Y4.27%
EPS Q2Q%62.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.77%
Revenue growth 3Y23.1%
Revenue growth 5Y6.74%
Sales Q2Q%25.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.15%
EBIT growth 3YN/A
EBIT growth 5Y8.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y688.82%
FCF growth 3Y-37.72%
FCF growth 5Y24.08%
OCF growth 1Y1433.15%
OCF growth 3Y54.71%
OCF growth 5Y61.92%